Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Monitor Group was a premier global strategy consulting firm founded in 1983 by Michael Porter and other Harvard Business School faculty. The firm was renowned for its expertise in competitive strategy and served a wide array of clients, including significant engagements within the life sciences, pharmaceutical, and healthcare industries through its dedicated Monitor Life Sciences practice. In 2013, after filing for bankruptcy protection, the firm was acquired by Deloitte and integrated into its consulting practice as Monitor Deloitte. The legacy of the firm continues through its strategic frameworks and its ongoing advisory work for major global biotech and pharma companies regarding market entry, product launch, and portfolio management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Monitor Company Group.